Efficacy and safety of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with type 2 diabetes and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, phase 3 trial
And we have healthier alternatives for the breakfast occasion [such as] belVita, which is a replacement snack, or some of our snack bars, which are meal replacements, and that fit perfectly into the diet of GLP-1 patients. With GLP-1 drugs, losing weight is definitely easier
Glucagon Like Peptide-1 Modulates Urinary Sodium Excretion In Diabetic Kidney Disease Via Enac Activation
Systolic blood pressure reduction with tirzepatide in patients with type 2 diabetes: insights from SURPASS clinical program